LONA
NASD LeonaBio, Inc.$5.04 ↓ -0.79 (-13.55%) Trading Down from the previous close of $5.83
- YTD change
- -23.05%
- vs 20-day SMA
- -9.87%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-3.75 (-39.14%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 64.5% away from all-time highs of $14.21
- LONA is down 23% since the beginning of the year
- LONA is down 23% over the past 12 months
- LONA is down 28% over the past 1 month
- 1% of all LONA investors are betting against LONA
LONA reads not so good: the 12-month move is -11.0%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +41.18%
- vs 8-day SMA
- +11.04%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
LeonaBio, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.